MedTrace Logo

Tumor and Development (TED)

NCT01915797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 998

Last updated 2026-02-13

No results posted yet for this study

Summary

The overall project goal is to build a database of childhood cancers associated with developmental anomalies; it aims at identifying new syndromes of genetic predisposition and at enabling the further study of their molecular basis.

Conditions

  • Tumor and Abnormalities of the Development

Interventions

OTHER

blood and tumor samples

all tumor pathology associated with anomaly of development

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Sabine SARNACKI, MD, PhD · Groupement Hospitalier Necker 149 rue de Sèvres 75015 PARIS France

Eligibility

Min Age
0 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01915797 on ClinicalTrials.gov